Corporate
Rezdiffra Hits $958M in Year One — But Madrigal Stock Drops 11%
Feb 19
You're signed outSign in or to get full access.
MP
MADRIGAL PHARMACEUTICALS (MDGL)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering MADRIGAL PHARMACEUTICALS.